ACE2 and COVID-19: Additionally, angiotensin-converting enzyme 2 (ACE2) was confirmed to be the cellular receptor for COVID-19 infection and entry [40] and was reduced in COVID-19 patients along with concomitant cellular damage, respiratory failure and hyperinflammation [40].